Eunice E. Kwon

2.2k total citations
17 papers, 1.8k citations indexed

About

Eunice E. Kwon is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Developmental Neuroscience. According to data from OpenAlex, Eunice E. Kwon has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 3 papers in Developmental Neuroscience. Recurrent topics in Eunice E. Kwon's work include Multiple Sclerosis Research Studies (6 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Axon Guidance and Neuronal Signaling (2 papers). Eunice E. Kwon is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Axon Guidance and Neuronal Signaling (2 papers). Eunice E. Kwon collaborates with scholars based in United States, United Kingdom and Australia. Eunice E. Kwon's co-authors include John W. Prineas, Leroy R. Sharer, Rita Barnard, Perry Z. Goldenberg, Emilia L. Oleszak, Brad E. Hoffman, Michael Barnett, B. Paul Morgan, Eun‐Sook Cho and Joyce A. Benjamins and has published in prestigious journals such as Brain, Annals of Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Eunice E. Kwon

16 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eunice E. Kwon United States 13 916 663 545 481 337 17 1.8k
Fatima König Germany 17 1.1k 1.2× 281 0.4× 538 1.0× 292 0.6× 310 0.9× 30 1.9k
Cheryl Reeves United Kingdom 13 1.0k 1.1× 250 0.4× 441 0.8× 300 0.6× 274 0.8× 18 1.8k
Francesca Ruffini Italy 21 341 0.4× 312 0.5× 571 1.0× 665 1.4× 170 0.5× 30 1.7k
Alastair Compston United Kingdom 24 607 0.7× 181 0.3× 187 0.3× 434 0.9× 225 0.7× 74 1.7k
Giuliana Salani Italy 15 361 0.4× 1.4k 2.2× 662 1.2× 1.0k 2.1× 762 2.3× 26 2.6k
Guus Wolswijk United Kingdom 22 556 0.6× 1.7k 2.6× 723 1.3× 813 1.7× 733 2.2× 29 2.4k
Rachel Mizrachi‐Kol Israel 11 267 0.3× 860 1.3× 384 0.7× 512 1.1× 350 1.0× 15 1.5k
Vijayabalan Balasingam Canada 12 236 0.3× 216 0.3× 551 1.0× 580 1.2× 248 0.7× 13 1.6k
P.-B. Andersson United States 15 300 0.3× 120 0.2× 618 1.1× 304 0.6× 302 0.9× 16 1.4k
Natalia Moll United States 7 892 1.0× 195 0.3× 333 0.6× 267 0.6× 86 0.3× 8 1.4k

Countries citing papers authored by Eunice E. Kwon

Since Specialization
Citations

This map shows the geographic impact of Eunice E. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunice E. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunice E. Kwon more than expected).

Fields of papers citing papers by Eunice E. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunice E. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunice E. Kwon. The network helps show where Eunice E. Kwon may publish in the future.

Co-authorship network of co-authors of Eunice E. Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Eunice E. Kwon. A scholar is included among the top collaborators of Eunice E. Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunice E. Kwon. Eunice E. Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kwon, Eunice E., Connor M. Kelley, Jennifer Pham, et al.. (2025). Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020. The Journal of Clinical Pharmacology. 65(8). 955–960.
2.
O’Connor, Maureen K., et al.. (2016). Enhanced vocational rehabilitation for Veterans with mild traumatic brain injury and mental illness: Pilot study. The Journal of Rehabilitation Research and Development. 53(3). 307–320. 17 indexed citations
3.
Kwon, Eunice E., Pablo M. Paez, Weihong Yan, et al.. (2015). Traumatically injured astrocytes release a proteomic signature modulated by STAT3‐dependent cell survival. Glia. 64(5). 668–694. 55 indexed citations
4.
Cushman, Jesse D., J. Maldonado, Eunice E. Kwon, et al.. (2012). Juvenile neurogenesis makes essential contributions to adult brain structure and plays a sex-dependent role in fear memories. Frontiers in Behavioral Neuroscience. 6. 3–3. 36 indexed citations
5.
Jang, Taichang, Joy M. Calaoagan, Eunice E. Kwon, et al.. (2010). 5′‐AMP‐activated protein kinase activity is elevated early during primary brain tumor development in the rat. International Journal of Cancer. 128(9). 2230–2239. 35 indexed citations
6.
Ringman, John M., et al.. (2010). The Use of Profanity During Letter Fluency Tasks in Frontotemporal Dementia and Alzheimer Disease. Cognitive and Behavioral Neurology. 23(3). 159–164. 9 indexed citations
7.
Prineas, John W., Eunice E. Kwon, Eun‐Sook Cho, et al.. (2001). Immunopathology of secondary‐progressive multiple sclerosis. Annals of Neurology. 50(5). 646–657. 315 indexed citations
8.
Capellari, Sabina, et al.. (2000). The Thr183Ala Mutation, Not the Loss of the First Glycosylation Site, Alters the Physical Properties of the Prion Protein. Journal of Alzheimer s Disease. 2(1). 27–35. 33 indexed citations
9.
Kwon, Eunice E. & John W. Prineas. (1994). Blood-Brain Barrier Abnormalities in Longstanding Multiple Sclerosis Lesions. An Immunohistochemical Study. Journal of Neuropathology & Experimental Neurology. 53(6). 625–636. 139 indexed citations
10.
Prineas, John W., et al.. (1993). Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions. Annals of Neurology. 33(2). 137–151. 461 indexed citations
11.
Prineas, John W., et al.. (1993). Multiple sclerosis. Brain. 116(3). 681–693. 178 indexed citations
12.
Goldenberg, Perry Z., et al.. (1990). Sera from MS patients and normal controls opsonize myelin. Neuroscience Letters. 109(3). 353–356. 2 indexed citations
13.
Prineas, John W., et al.. (1990). Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.. PubMed. 63(5). 624–36. 59 indexed citations
14.
Prineas, John W., Eunice E. Kwon, Perry Z. Goldenberg, et al.. (1989). Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.. PubMed. 61(5). 489–503. 230 indexed citations
15.
Prineas, John W., et al.. (1987). MULTIPLE SCLEROSIS. Journal of Neuropathology & Experimental Neurology. 46(3). 366–366. 3 indexed citations
16.
Prineas, John W., Eunice E. Kwon, Nancy H. Sternberger, & Vanda A. Lennon. (1984). The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions. Journal of Neuroimmunology. 6(4). 251–264. 43 indexed citations
17.
Prineas, John W., et al.. (1984). Continual Breakdown and Regeneration of Myelin in Progressive Multiple Sclerosis Plaquesa. Annals of the New York Academy of Sciences. 436(1). 11–32. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026